Silodosin

規格

160970-54-7CAS番号

814-909-2EC番号

1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamideIUPAC名

C25H32F3N3O4化学式

495.5 g/mol分子量

Silodosin; 160970-54-7; Urief; Rapaflo; Silodyx; KMD-3213; Urorec; Rapilif; Silodal; KAD-3213; silodosine; Silodosina; KSO-0400; CUZ39LUY82; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide; DTXSID40167045; 1-(3-hydroxypropyl)-5-[(2r)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1h-indole-7-carboxamide; 1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide; silodosinum; 1-(3-Hydroxypropyl)-5-((2R)-2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide; 1-(3-hydroxypropyl)-5-((2R)-2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)-2,3-dihydroindole-7-carboxamide; RefChem:56683; DTXCID3089536; G04CA04; KMD 3213; (-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide; MFCD00930170; (R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide; 1H-Indole-7-carboxamide, 2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-; CHEMBL24778; 2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide; C25H32F3N3O4; Rapflo; Silodosin [INN]; (-)-1-(3-Hydroxypropyl)-5-((2R)-2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide; (R)-1-(3-Hydroxypropyl)-5-[2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]indoline-7-carboxamide; Silodosin [INN:BAN]; KAD 3213; UNII-CUZ39LUY82; 2,3-DIHYDRO-1-(3-HYDROXYPROPYL)-5-((2R)-2-((2-(2-(2,2,2-TRIFLUOROETHOXY)PHENOXY)ETHYL)AMINO)PROPYL)-1H-INDOLE-7-CARBOXAMIDE; Rapaflo (TN); Silodosin (Rapaflo); 1-(3-Hydroxypropy; Silodosin (Standard); Urief (TN); Silodosin Impurity 13; A1EMV; SILODOSIN [JAN]; SILODOSIN [MI]; SILODOSIN [VANDF]; Silodosin (JP18/INN); SILODOSIN [MART.]; SILODOSIN [WHO-DD]; GTPL493; SILODOSIN [EMA EPAR]; MLS006010022; SCHEMBL136973; orb1226063; orb1308412; SILODOSIN [ORANGE BOOK]; SCHEMBL29967021; Silodosin, >=98% (HPLC); KMD3213; CHEBI:135929; GLXC-03240; HMS3715B06; HMS3884O21; BDBM50160154; EBC-27231; HY-10122R; s1613; AKOS005145899; KAD 3213;KMD 3213; BS-1011; CCG-221202; CS-0284; DB06207; FS27830; NCGC00345882-03; NCGC00345882-04; 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide; AC-22605; HY-10122; SMR004701206; SY111942; I1128; SW219765-1; D01965; SBI-0654161.0001; EN300-6481367; F544694; Q411770; SR-01000944157; SR-01000944157-1; BRD-K10906636-001-01-1; BRD-K10906636-001-02-9; Z2235802137; (R)-1-(3 -Hydroxypropyl)-5-[2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]indoline-7-carboxamide; (r)-1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide; (R)-5-[2-[[2-[2-(2,2,2-trifluoro-ethoxy)phenoxy]ethyl]amino]propyl]-1-(3-hydroxypropyl)-2,3-dihydro-1H-indole-7-carboxamide; 1-(3-Hydroxy-propyl)-5-((R)-2-{2-[2-(2,2,2-trifluoro-ethoxy)-phenoxy]-ethylamino}-propyl)-2,3-dihydro-1H-indole-7-carboxylic acid amide; 1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]-ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide別名